Steffimycin

DB19922ExperimentalSmall molecule

Steffimycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Steffimycin is a antibiotic, produced by Streptomyces strain. Steffimycin has a monoisotopic...

Mechanism: Pharmacologically active on DNA-directed RNA polymerase subunit beta and DNA polymerase III subunit epsilon
Curator reviewed
Formula / weight: C₂₈H₃₀O₁₃ · 574.535 g/mol (avg)
Code names: NSC-93419 · U-20,661

Resolves to

Compound

UNII48V353KY77CAS11033-34-4ChEMBLCHEMBL2105537

Structure

InChIKeyHWMJTJZEJBSVCG-GPDBLRFJSA-NSMILESCO[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC)[C@](C)(O)C(=O)C2=C1C(O)=C1C(=O)C3=C(C=C(OC)C=C3O)C(=O)C1=C2

Targets

P0A8V2rpoBP03007dnaQ

What you can answer from here — as of September 19, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Steffimycin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account